Literature DB >> 18706683

The incidence of deep vein thrombosis in women undergoing cesarean delivery.

Winnie W Sia1, Raymond O Powrie, Ann B Cooper, Lucia Larson, Maureen Phipps, Patricia Spencer, Nadine Sauve, Karen Rosene-Montella.   

Abstract

INTRODUCTION: Venous thromboembolism (VTE) is one of the leading causes of maternal mortality in the United States. Cesarean delivery is a known risk factor. This study was to determine the incidence of deep vein thrombosis (DVT) post cesarean delivery.
MATERIALS AND METHODS: This was a prospective cohort study where two patients having undergone cesarean delivery each day were randomly selected. A lower extremity compression ultrasound was performed prior to hospital discharge. If no DVT was detected, participants were asked to return for a second ultrasound two weeks postpartum. Participants were also telephone-interviewed at three months for reported VTE.
RESULTS: Of the 194 patients who consented to study participation, only one participant developed DVT after cesarean delivery, giving an overall incidence of 0.5% (95% CI, 0.1 to 2.8%). There were no DVT identified on the second ultrasound nor VTE reported 3 months postpartum.
CONCLUSIONS: We found the DVT rate after cesarean delivery to be 0.5%.

Entities:  

Mesh:

Year:  2008        PMID: 18706683     DOI: 10.1016/j.thromres.2008.06.004

Source DB:  PubMed          Journal:  Thromb Res        ISSN: 0049-3848            Impact factor:   3.944


  6 in total

1.  VTE, thrombophilia, antithrombotic therapy, and pregnancy: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.

Authors:  Shannon M Bates; Ian A Greer; Saskia Middeldorp; David L Veenstra; Anne-Marie Prabulos; Per Olav Vandvik
Journal:  Chest       Date:  2012-02       Impact factor: 9.410

Review 2.  Pulmonary embolism in pregnancy.

Authors:  E Conti; L Zezza; E Ralli; C Comito; L Sada; J Passerini; D Caserta; S Rubattu; C Autore; M Moscarini; M Volpe
Journal:  J Thromb Thrombolysis       Date:  2014-04       Impact factor: 2.300

3.  Guidance for the treatment and prevention of obstetric-associated venous thromboembolism.

Authors:  Shannon M Bates; Saskia Middeldorp; Marc Rodger; Andra H James; Ian Greer
Journal:  J Thromb Thrombolysis       Date:  2016-01       Impact factor: 2.300

4.  Postpartum venous thromboembolism prophylaxis may cause more harm than benefit: a critical analysis of international guidelines through an evidence-based lens.

Authors:  A Kotaska
Journal:  BJOG       Date:  2018-03-07       Impact factor: 6.531

5.  Efficacy and safety of venous thromboembolism prophylaxis with fondaparinux in women at risk after cesarean section.

Authors:  Ryuji Kawaguchi; Shoji Haruta; Hiroshi Kobayashi
Journal:  Obstet Gynecol Sci       Date:  2017-10-17

6.  The efficacy and safety of pharmacologic thromboprophylaxis following caesarean section: A systematic review and meta-analysis.

Authors:  Rui Yang; Xia Zhao; Yilei Yang; Xin Huang; Hongjian Li; Lequn Su
Journal:  PLoS One       Date:  2018-12-10       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.